Wells Fargo Starts Celgene (CELG) at Outperform, Valuation Range of $65-$69

December 10, 2010 8:48 AM EST Send to a Friend
Wells Fargo initiates coverage on Celgene (NASDAQ: CELG) with an Outperform rating and a valuation range of $65-$69. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login